Chu H

ORCID: 0009-0007-5429-4429 · 5 papers in corpus
other 2026
BMC pregnancy and childbirth ·doi:10.1186/s12884-026-09268-x

OBJECTIVE: This study aims to identify the most diagnostically valuable features among the 11 MRI features of Placenta accreta spectrum (PAS) described in the joint consensus statement by the Society of Abdominal Radiology (SAR) and the Eur…

case-report 2025
Medicine ·doi:10.1097/md.0000000000044328

RATIONALE: Myocardial infarction with nonobstructive coronary arteries (MINOCA) has diverse ischemic etiologies and has been defined by the absence of angiographically significant obstructive coronary artery disease. Blood transfusion has s…

review 2025
Medicine ·doi:10.1097/md.0000000000042828

RATIONALE: Low-grade appendiceal mucinous neoplasm (LAMN) is a rare subtype of appendiceal pathology characterized by epithelial hyperplasia, cellular atypia, and mucinous accumulation within the appendiceal lumen, leading to obstructive ex…

lab-animal 2024
Physiological Research ·doi:10.33549/physiolres.935303

The endothelial-mesenchymal transition (EndMT) of endothelial progenitor cells (EPCs) plays a notable role in pathological vascular remodeling. Emerging evidence indicated that long non-coding RNA-regulator of reprogramming (linc-ROR) can p…

other 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0587-0

Growing evidence indicates that the tumor biomarker cytokeratin 19 fragment (CYFRA21-1) is significant for a variety of cancers. However, its role in epithelial ovarian cancer (EOC) has rarely been reported. In this study, a receiver operat…